@JSBStrikesBack
Further to your post, I attach a very recent tweet from former FDA Commissioner Dr Scott Gottlieb who just minutes ago wrote that there is a growing body of evidence that recovering COVID 19 patients are presenting with cardiac abdormailities probably associated with inflammation and scarring IMO. An area that we all know Mesoblast has years of experience in and a likely product candidate. The stromal cells have the ability to target multiple areas of inflammation and the homing of these cells is all encompassing.
All positive signs for Mesoblast.
Cell Therapy News/Articles, page-5442
-
- There are more pages in this discussion • 12,331 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.14 |
Change
0.050(4.59%) |
Mkt cap ! $1.301B | |||
| Open | High | Low | Value | Volume |
| $1.10 | $1.14 | $1.08 | $6.654M | 5.972M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 1330 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.14 | 171164 | 10 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |